背景:新的治疗方法和技术具有先进的糖尿病护理;然而,糖尿病继续对患者的日常生活产生重大影响,尤其是在应得公平的群体中。来自患者参与文献的证据表明,让不同的患者参与医疗保健可以创造具有成本效益的改善,并提高护理效率,具有很高的患者可接受性和许多健康益处。以及提高供应商满意度。将进行范围审查,以提供对患者参与实践和由此产生的结果的凝聚力和全面的理解。
方法:审查将遵循JoannaBriggs研究所(JBI)范围审查方法小组制定的范围审查建议。审查将包括1990年1月1日至今出版的英文文献,通过MEDLINE(Ovid)搜索,Embase(Ovid),CINAHL(EBSCOhost),PsycINFO(Ovid),国际社会科学参考书目(IBSS),社会学文摘,应用社会科学索引和摘要(ASSIA),Scopus,社会科学引文索引和坎贝尔合作;手工搜索;和灰色文献。描述参与概念化的文献,不同级别糖尿病护理的参与和/或参与评估的方法/策略,包括直接护理,将包括组织设计、治理和政策制定。审查将包括定量,定性和混合方法研究。次要的研究,以英语以外的其他语言出版,或不特别关注患者参与将被排除。筛选和提取将由两名独立审稿人完成,冲突将通过讨论或第三名审稿人解决,每一步都在驾驶。研究将通过描述性数字摘要和内容分析进行分析。
背景:这项工作没有道德或安全方面的考虑。结果将会分发给病人/病人倡导团体,糖尿病组织,临床医生,研究人员,决策者和决策者通过摘要文件的方式,信息图表,会议介绍和通过同行评审的出版物。
背景:该协议已在OpenScienceFramework中注册:https://doi.org/10.17605/OSF。IO/KCD7Z。
BACKGROUND: New treatments and technologies have advanced diabetes care; however, diabetes continues to have a major impact on the daily lives of affected individuals, especially among equity-deserving groups. Evidence from patient engagement literature suggests that involving diverse patients in healthcare can create cost-effective improvements and enhanced efficiency in care that has high patient acceptability and numerous health benefits, as well as improved provider satisfaction. A scoping review will be conducted to provide a cohesive and comprehensive understanding of patient engagement practices and the resulting outcomes.
METHODS: The review will follow the recommendations for the conduct of scoping reviews developed by the Joanna Briggs Institute (JBI) Scoping Review Methodology Group. The review will include English-language literature published between 1 January 1990 and the present, searched through MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), PsycINFO (Ovid), International Bibliography of the Social Sciences (IBSS), Sociological Abstracts, Applied Social Sciences Index and Abstracts (ASSIA), Scopus, Social Sciences Citation Index and Campbell Collaboration; hand searches; and grey literature. Literature that describes conceptualisations of engagement, methods/strategies for engagement and/or evaluations of engagement across different levels of diabetes care, including direct care, organisational design and governance and policymaking will be included. The review will encompass quantitative, qualitative and mixed-methods studies. Research that is secondary, published in languages other than English, or not specifically focused on patient engagement will be excluded. Screening and extraction will be completed by two independent reviewers and conflicts will be resolved by discussion or a third reviewer, with piloting at each step. Studies will be analysed through descriptive numerical summary and content analysis.
BACKGROUND: No ethical or safety considerations are pertinent to this work. The results will be disseminated to patients/patient advocacy groups, diabetes organisations, clinicians, researchers, decision-makers and policymakers by way of summary documents, infographics, meeting presentations and through peer-reviewed publications.
BACKGROUND: The protocol has been registered with Open Science Framework: https://doi.org/10.17605/OSF.IO/KCD7Z.